Mayank Bansal, CFA
Mayank Bansal is a CFA Charterholder and heads the Equity Research team at Kapitales Research, with over 5 years of experience analysing global equity markets. He leads fundamental, data-driven research combining rigorous financial analysis with macro trends.
Plato Income Maximiser Reports AU$41.8 Million FY26 Profit as Portfolio Return Matches Benchmark
Highlights
Plato Income Maximiser Reports FY26 Results
Plato Income Maximiser Limited (ASX: PL8) announced its financial results for the year ended 30 June 2026 on 26 August 2026, reporting a profit of AU$41.8 million. The company's investment portfolio delivered a total return of 7.2% during FY26, matching the performance of its benchmark.
The company said its portfolio exceeded the benchmark from an income perspective, generating distributed income of 6.7%, including franking credits, compared with 4.2% for the benchmark. Since inception, PL8 has delivered an annualised total return of 10.0%, slightly above the benchmark's 9.9%.
Monthly Dividends Remain at AU$0.0055 Per Share
Dividend income remained a key feature of PL8's FY26 performance. The company paid 12 consecutive monthly dividends of AU$0.0055 per share, taking the total distribution for the year to AU$0.066 per share. This represented a distributed yield of 6.7% for the financial year. Following the end of FY26, the company resolved to maintain the monthly dividend at AU$0.0055 per share for three additional months. The first payment was made on 31 July 2026, followed by payments scheduled for 31 August and 30 September 2026. The Board said it would continue assessing market yields and the company's franking position when determining future distributions.
Portfolio Performance and Investment Outlook
PL8's pre-tax net tangible assets (NTA) per share stood at AU$1.144 at 30 June 2026, compared with AU$1.153 a year earlier. The reduction followed the payment of AU$0.066 per share in fully franked dividends during the year. Post-tax NTA was AU$1.133 per share. The portfolio's strongest contributors to active performance included an overweight position in South32 and underweight positions in CSL, WiseTech, Commonwealth Bank and Cochlear.
Meanwhile, Insurance Australia Group and Suncorp were among the largest detractors. PL8 said its portfolio remains positioned to pursue higher income than the benchmark, with the company anticipating an improved dividend environment in FY27, particularly across resource stocks following stronger commodity prices.
Note- All data presented is based on information available at the time of writing.
Disclaimer for Kapitales Research
The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.Disclosure: The information mentioned above has been sourced from the company reports and a third-party database, i.e. Koyfin. Investors are advised to use strict stop-loss to protect their investments in case of any unfavorable/uncertain market events.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au